OpenFDA: an innovative platform providing access to a wealth of FDA's publicly available data.
Objective: The objective of openFDA is to facilitate access and use of big important Food and Drug Administration public datasets by developers, researchers, and the public through harmonization of data across disparate FDA datasets provided via application programming interfaces (APIs).Materials an...
| Publicado en: | Journal of the American Medical Informatics Association Vol. 23; no. 3; pp. 596 - 601 |
|---|---|
| Autores principales: | , , , , , , , , |
| Formato: | tables/charts Journal Article |
| Publicado: |
Oxford University Press / USA
May2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=116910475&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 116910475 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10675027 FZ9 jtl: Journal of the American Medical Informatics Association issn: 10675027 maglogo: N pubinfo: dt: May2016 vid: 23 iid: 3 pid: 622 pub: Oxford University Press / USA artinfo: ui: 116910475 116910475 NLM26644398 116910475 10.1093/jamia/ocv153 NLM26644398 PMC4901374 [Available on 05/01/17] 116910475 ppf: 596 ppct: 5 formats: tig: atl: OpenFDA: an innovative platform providing access to a wealth of FDA's publicly available data. aug: au: Kass-Hout, Taha A. Zhiheng Xu Mohebbi, Matthew Nelsen, Hans Baker, Adam Levine, Jonathan Johanson, Elaine Bright, Roselie A. Xu, Zhiheng affil: U.S. Food and Drug Administration, Silver Spring, MD, USA sug: subj: Software Data Collection Adverse Drug Event United States Food and Drug Administration United States Product Recall Drug Labeling Product Acquisition Government Regulations ab: Objective: The objective of openFDA is to facilitate access and use of big important Food and Drug Administration public datasets by developers, researchers, and the public through harmonization of data across disparate FDA datasets provided via application programming interfaces (APIs).Materials and Methods: Using cutting-edge technologies deployed on FDA's new public cloud computing infrastructure, openFDA provides open data for easier, faster (over 300 requests per second per process), and better access to FDA datasets; open source code and documentation shared on GitHub for open community contributions of examples, apps and ideas; and infrastructure that can be adopted for other public health big data challenges.Results: Since its launch on June 2, 2014, openFDA has developed four APIs for drug and device adverse events, recall information for all FDA-regulated products, and drug labeling. There have been more than 20 million API calls (more than half from outside the United States), 6000 registered users, 20,000 connected Internet Protocol addresses, and dozens of new software (mobile or web) apps developed. A case study demonstrates a use of openFDA data to understand an apparent association of a drug with an adverse event.Conclusion: With easier and faster access to these datasets, consumers worldwide can learn more about FDA-regulated products. pubtype: Academic Journal doctype: tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|